全文获取类型
收费全文 | 1192篇 |
免费 | 63篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 66篇 |
妇产科学 | 39篇 |
基础医学 | 144篇 |
口腔科学 | 20篇 |
临床医学 | 188篇 |
内科学 | 240篇 |
皮肤病学 | 17篇 |
神经病学 | 36篇 |
特种医学 | 119篇 |
外科学 | 199篇 |
综合类 | 10篇 |
预防医学 | 98篇 |
眼科学 | 2篇 |
药学 | 47篇 |
肿瘤学 | 40篇 |
出版年
2021年 | 11篇 |
2019年 | 24篇 |
2018年 | 14篇 |
2017年 | 11篇 |
2016年 | 12篇 |
2015年 | 17篇 |
2014年 | 26篇 |
2013年 | 59篇 |
2012年 | 47篇 |
2011年 | 56篇 |
2010年 | 47篇 |
2009年 | 50篇 |
2008年 | 38篇 |
2007年 | 58篇 |
2006年 | 46篇 |
2005年 | 42篇 |
2004年 | 37篇 |
2003年 | 28篇 |
2002年 | 27篇 |
2001年 | 10篇 |
2000年 | 10篇 |
1999年 | 18篇 |
1998年 | 48篇 |
1997年 | 50篇 |
1996年 | 37篇 |
1995年 | 23篇 |
1994年 | 28篇 |
1993年 | 19篇 |
1992年 | 21篇 |
1991年 | 15篇 |
1990年 | 13篇 |
1989年 | 25篇 |
1988年 | 39篇 |
1987年 | 23篇 |
1986年 | 18篇 |
1985年 | 19篇 |
1984年 | 15篇 |
1983年 | 17篇 |
1982年 | 21篇 |
1981年 | 12篇 |
1980年 | 15篇 |
1978年 | 12篇 |
1977年 | 14篇 |
1976年 | 12篇 |
1975年 | 9篇 |
1973年 | 12篇 |
1969年 | 10篇 |
1968年 | 7篇 |
1967年 | 5篇 |
1966年 | 5篇 |
排序方式: 共有1277条查询结果,搜索用时 15 毫秒
51.
BJ Ferguson MD 《International forum of allergy & rhinology》2014,4(5):345-346
52.
53.
Setting priorities in global child health research investments: assessment of principles and practice 总被引:2,自引:2,他引:0
下载免费PDF全文
![点击此处可从《Croatian medical journal》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Rudan I Gibson J Kapiriri L Lansang MA Hyder AA Lawn J Darmstadt GL Cousens S Bhutta ZA Brown KH Hess SY Black M Gardner JM Webster J Carneiro I Chandramohan D Kosek M Lanata CF Tomlinson M Chopra M Ameratunga S Campbell H El Arifeen S Black RE;Child Health Nutrition Research Initiative 《Croatian medical journal》2007,48(5):595-604
This article reviews theoretical and practical approaches for setting priorities in global child health research investments. It also provides an overview of previous attempts to develop appropriate tools and methodologies to define priorities in health research investments. A brief review of the most important theoretical concepts that should govern priority setting processes is undertaken, showing how different perspectives, such as medical, economical, legal, ethical, social, political, rational, philosophical, stakeholder driven, and others will necessarily conflict each other in determining priorities. We specially address present research agenda in global child health today and how it relates to United Nation's (UN) Millennium Development Goal 4, which is to reduce child mortality by two-thirds between 1990 and 2015. The outcomes of these former approaches are evaluated and their benefits and shortcomings presented. The case for a new methodology for setting priorities in health research investments is presented, as proposed by Child Health and Nutrition Research Initiative, and a need for its implementation in global child health is outlined. A transdisciplinary approach is needed to address all the perspectives from which investments into health research can be seen as priorities. This prioritization requires a process that is transparent, systematic, and that would take into account many perspectives and build on advantages of previous approaches. 相似文献
54.
Setting priorities in global child health research investments: addressing values of stakeholders
下载免费PDF全文
![点击此处可从《Croatian medical journal》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Kapiriri L Tomlinson M Chopra M El Arifeen S Black RE Rudan I;Child Health Nutrition Research Initiative 《Croatian medical journal》2007,48(5):618-627
Aim
To identify main groups of stakeholders in the process of health research priority setting and propose strategies for addressing their systems of values.Methods
In three separate exercises that took place between March and June 2006 we interviewed three different groups of stakeholders: 1) members of the global research priority setting network; 2) a diverse group of national-level stakeholders from South Africa; and 3) participants at the conference related to international child health held in Washington, DC, USA. Each of the groups was administered different version of the questionnaire in which they were asked to set weights to criteria (and also minimum required thresholds, where applicable) that were a priori defined as relevant to health research priority setting by the consultants of the Child Health and Nutrition Research initiative (CHNRI).Results
At the global level, the wide and diverse group of respondents placed the greatest importance (weight) to the criterion of maximum potential for disease burden reduction, while the most stringent threshold was placed on the criterion of answerability in an ethical way. Among the stakeholders’ representatives attending the international conference, the criterion of deliverability, answerability, and sustainability of health research results was proposed as the most important one. At the national level in South Africa, the greatest weight was placed on the criterion addressing the predicted impact on equity of the proposed health research.Conclusions
Involving a large group of stakeholders when setting priorities in health research investments is important because the criteria of relevance to scientists and technical experts, whose knowledge and technical expertise is usually central to the process, may not be appropriate to specific contexts and in accordance with the views and values of those who invest in health research, those who benefit from it, or wider society as a whole.When decisions on investments in health research are made, the term “stakeholders” refers to all individuals and/or groups who have interest in prioritization of those investments. The stakeholders will therefore comprise a large and highly heterogeneous group. Some apparent examples may include research funding agencies (eg, governmental agencies, private organizations, public-private partnerships, international and regional organizations, and taxpayers of a certain region), direct recipients of the funding (eg, researchers and research institutions), beneficiaries of the research (eg, policy makers and the general population of a country), and any other group with interest in prioritization process (eg, advocacy groups, journalists and media, lawyers, economists, experts in ethics, and many others).Two fundamental characteristics of any acceptable and successful priority setting process are legitimacy and fairness (1). In order to ensure the legitimacy and fairness of the priority setting decisions in health research investments, involvement of a wide range of stakeholders (and/or eliciting their values) is needed. Unfortunately, health research priorities are presently mainly driven by technical experts (2-5). The results of prioritization are therefore in danger of being mostly influenced by their personal views, with minimal input from representatives from the wider community who also may have interest in the process but lack technical expertise. Since the values and criteria important to scientists and technical experts may vary remarkably from those of other relevant stakeholders (6-8), the relevance of eliciting wider stakeholders’ input is increasingly being acknowledged (9-11). However, the main challenge is to develop a systematic, flexible, and repeatable strategy on how this can be achieved in different contexts.The literature on priority setting for health interventions identifies two main strategies: 1) stakeholders’ values may impact decisions through procedural processes (by having access to the decisions and the rationales behind the decisions, and by having the authority to deliberate on the decisions and influence the final outcome); 2) stakeholders’ values can be directly elicited using quantitative methods (through surveys where respondents rank, weigh, or rate their values) and qualitative methods (involving individual interviews, Delphi technique, complaints procedures or group discussions, concept mapping, citizen’s jury, and public meetings) (12). The main challenges in those attempts have mainly been the lack of capacity for some stakeholders to engage in meaningful deliberations (13) and how to practically incorporate the elicited stakeholders’ values in decision-making (12,14). This paper presents our suggestions and experiences on how the values and interests of large and diverse group of stakeholders could still be incorporated in decisions on health research investment priorities. We specified thresholds and weights needed to address stakeholders’ values within CHNRI methodology using three different versions of a questionnaire. We aimed to assess stakeholders’ values for priority setting in global health research investments. We tested questionnaires that presented different levels of complexity and detail of the questions that stakeholders’ representatives would be asked. We also aimed to evaluate different strategies of turning their responses into numerical thresholds and weights. 相似文献55.
Neha J. Goel BA Shiri Sadeh‐Sharvit PhD Rachael E. Flatt BS Mickey Trockel MD PhD Katherine N. Balantekin PhD RD Ellen E. Fitzsimmons‐Craft PhD Grace E. Monterubio BA Marie-Laure Firebaugh MSW Corinna Jacobi PhD Denise E. Wilfley PhD C. Barr Taylor MD 《The International journal of eating disorders》2018,51(6):579-584
56.
57.
Tait D. Shanafelt Colin P. West Christine Sinsky Mickey Trockel Michael Tutty Daniel V. Satele Lindsey E. Carlasare Lotte N. Dyrbye 《Mayo Clinic proceedings. Mayo Clinic》2019,94(9):1681-1694
ObjectiveTo evaluate the prevalence of burnout and satisfaction with work-life integration among physicians and other US workers in 2017 compared with 2011 and 2014.Participants and MethodsBetween October 12, 2017, and March 15, 2018, we surveyed US physicians and a probability-based sample of the US working population using methods similar to our 2011 and 2014 studies. A secondary survey with intensive follow-up was conducted in a sample of nonresponders to evaluate response bias. Burnout and work-life integration were measured using standard tools.ResultsOf 30,456 physicians who received an invitation to participate, 5197 (17.1%) completed surveys. Among the 476 physicians in the secondary survey of nonresponders, 248 (52.1%) responded. A comparison of responders in the 2 surveys revealed no significant differences in burnout scores (P=.66), suggesting that participants were representative of US physicians. When assessed using the Maslach Burnout Inventory, 43.9% (2147 of 4893) of the physicians who completed the MBI reported at least one symptom of burnout in 2017 compared with 54.4% (3680 of 6767) in 2014 (P<.001) and 45.5% (3310 of 7227) in 2011 (P=.04). Satisfaction with work-life integration was more favorable in 2017 (42.7% [2056 of 4809]) than in 2014 (40.9% [2718 of 6651]; P<.001) but less favorable than in 2011 (48.5% [3512 of 7244]; P<.001). On multivariate analysis adjusting for age, sex, relationship status, and hours worked per week, physicians were at increased risk for burnout (odds ratio, 1.39; 95% CI, 1.26-1.54; P<.001) and were less likely to be satisfied with work-life integration (odds ratio, 0.77; 95% CI, 0.70-0.85; P<.001) than other working US adults.ConclusionBurnout and satisfaction with work-life integration among US physicians improved between 2014 and 2017, with burnout currently near 2011 levels. Physicians remain at increased risk for burnout relative to workers in other fields. 相似文献
58.
59.
Effects of a novel antiplatelet agent in mural thrombogenesis on collagen-coated glass 总被引:2,自引:1,他引:2
A parallel plate flow chamber and an epifluorescence video microscopy system were used to investigate the inhibitory effect of a novel antiplatelet agent (GT-12), a carbamoylpiperidine congener, on surface platelet aggregation and on the kinetics of thrombus growth induced by collagen-coated glass under controlled flow. Both macroscopic and microscopic measurements revealed that increasing concentrations of the drug correspondingly decreased the reaction rate between platelets at the surface, thereby reducing thrombus rate of growth at the surface. Because of decreased platelet/platelet adhesion, there was some embolization of the larger thrombi near the inlet of the reactive surface. In the presence of GT-12, average thrombus size and number of platelets per thrombus were both strikingly lowered. In addition, the net rate of growth of individual thrombi decreased to zero after short exposure times (about 60 seconds), in sharp contrast to controls. In contrast to chlorpromazine, GT-12 was effective in inhibiting platelet aggregation and thrombus rate of growth at relatively low concentrations (less than 100 mumol/L) in whole blood. The drug's effectiveness relative to controls in impeding platelet/platelet interactions was found to increase with decreasing incubation time and increasing perfusion time. 相似文献
60.
South Africa Every Death Counts Writing Group Bradshaw D Chopra M Kerber K Lawn JE Bamford L Moodley J Pattinson R Patrick M Stephen C Velaphi S 《Lancet》2008,371(9620):1294-1304
South Africa is one of the few developing countries with a national confidential inquiry into maternal deaths. 164 health facilities obtain audit data for stillbirths and neonatal deaths, and a new audit network does so for child deaths. Three separate reports have been published, providing valuable information about avoidable causes of death for mothers, babies, and children. These reports make health-system recommendations, many of which overlap and are intertwined with the scarcity of progress in addressing HIV/AIDS. The leaders of these three reports have united to prioritise actions to save the lives of South Africa's mothers, babies, and children. The country is off-track for the health-related Millennium Development Goals. Mortality in children younger than 5 years has increased, whereas maternal and neonatal mortality remain constant. This situation indicates the challenge of strengthening the health system because of high inequity and HIV/AIDS. Coverage of services is fairly high, but addressing the gaps in quality and equity is essential to increasing the number of lives saved. Consistent leadership and accountability to address crosscutting health system and equity issues, and to prevent mother-to-child transmission of HIV, would save tens of thousands of lives every year. Audit is powerful, but only if the data lead to action. 相似文献